Citas bibligráficas
Rodriguez, J., (2023). Análisis del tratamiento periodístico de la eficacia de la vacuna Sinopharm contra la COVID-19 en el programa ‘Beto a Saber’ en el año 2021 [Tesis, Universidad Privada del Norte]. https://hdl.handle.net/11537/36634
Rodriguez, J., Análisis del tratamiento periodístico de la eficacia de la vacuna Sinopharm contra la COVID-19 en el programa ‘Beto a Saber’ en el año 2021 [Tesis]. PE: Universidad Privada del Norte; 2023. https://hdl.handle.net/11537/36634
@misc{renati/519734,
title = "Análisis del tratamiento periodístico de la eficacia de la vacuna Sinopharm contra la COVID-19 en el programa ‘Beto a Saber’ en el año 2021",
author = "Rodriguez Tipismana, Johnny Alfonso",
publisher = "Universidad Privada del Norte",
year = "2023"
}
In the coronavirus pandemic, the media played a crucial role in reporting on this new virus that implied various restrictions such as confinement and other incidents linked to public health at that time. Therefore, it was decided to study one of the most important journalistic programs on Willax Television, “Beto a Saber”, hosted by the Peruvian journalist Humberto Martín Ortiz Pajuelo. This research aimed to analyze the journalistic treatment of the effectiveness of the Chinese Sinopharm vaccine against COVID-19 in 2021 in the aforementioned program. The work was developed under a qualitative approach and descriptive, non-experimental design. The variable was journalistic treatment and the technique of observation sheets was applied, addressing the dimensions of news, message and responsibility. As an object of study, three broadcasts of the program were collected in March of that same year, in which the scoop on the level of effectiveness of the Sinopharm vaccine was presented. It was concluded that there were shortcomings in the way the information regarding effectiveness was treated. In addition, a campaign to discredit the Sinopharm vaccine was evident on the part of that television space, without considering the effects that the news associated with this topic could have on its audience.
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons